Dynavax Technologies (DVAX) News Today → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free DVAX Stock Alerts $11.99 +0.17 (+1.44%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28, 2024 | prnewswire.comDynavax to Present at Upcoming Investor ConferencesMay 28, 2024 | marketbeat.comDimensional Fund Advisors LP Has $56.37 Million Stock Holdings in Dynavax Technologies Co. (NASDAQ:DVAX)Dimensional Fund Advisors LP lifted its holdings in Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 7.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,032,139 shares of the biopharmaceutical companyMay 28, 2024 | americanbankingnews.comDynavax Technologies (NASDAQ:DVAX) Lowered to Hold at StockNews.comMay 28, 2024 | marketbeat.comDynavax Technologies (NASDAQ:DVAX) Rating Lowered to Hold at StockNews.comStockNews.com downgraded Dynavax Technologies from a "buy" rating to a "hold" rating in a research note on Tuesday.May 26, 2024 | americanbankingnews.comDynavax Technologies (NASDAQ:DVAX) Stock Price Down 3.4%May 24, 2024 | marketbeat.comTrexquant Investment LP Buys 89,521 Shares of Dynavax Technologies Co. (NASDAQ:DVAX)Trexquant Investment LP lifted its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 51.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 263,912 shares of the biopharmaceutical company's stock aftMay 21, 2024 | marketbeat.comDynavax Technologies (NASDAQ:DVAX) Stock Rating Upgraded by StockNews.comStockNews.com raised Dynavax Technologies from a "hold" rating to a "buy" rating in a research report on Monday.May 20, 2024 | marketbeat.comBNP Paribas Financial Markets Has $5.78 Million Stock Holdings in Dynavax Technologies Co. (NASDAQ:DVAX)BNP Paribas Financial Markets boosted its position in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 23.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 413,409 shares of the biopharmaceutMay 19, 2024 | marketbeat.comGreat Lakes Advisors LLC Has $6.83 Million Stock Position in Dynavax Technologies Co. (NASDAQ:DVAX)Great Lakes Advisors LLC lessened its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 34.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 488,772 shares of the biopharmacMay 15, 2024 | marketbeat.comBrokers Set Expectations for Dynavax Technologies Co.'s Q1 2025 Earnings (NASDAQ:DVAX)Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) - Research analysts at William Blair issued their Q1 2025 EPS estimates for Dynavax Technologies in a note issued to investors on Tuesday, May 14th. William Blair analyst M. Phipps anticipates that the biopharmaceutical company will earn $0.03May 14, 2024 | finanznachrichten.deDynavax Technologies: Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B Regimen for Adults on Hemodialysis in the U.S.May 14, 2024 | markets.businessinsider.comHold Rating on Dynavax Amidst FDA Setback and Long-term Profitability FocusMay 14, 2024 | markets.businessinsider.comDynavax Receives FDA's CRL Regarding Four-Dose Heplisav-B Vaccine For Hemodialysis PatientsMay 14, 2024 | msn.comFDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis PatientsMay 14, 2024 | marketbeat.comDynavax Technologies (NASDAQ:DVAX) Shares Gap Down to $11.03Dynavax Technologies (NASDAQ:DVAX) Shares Gap Down to $11.03May 14, 2024 | finance.yahoo.comUPDATE 1-US FDA declines to approve expanded use of Dynavax's hepatitis B vaccineMay 14, 2024 | reuters.comUS FDA declines to approve expanded use of Dynavax's hepatitis B vaccineMay 14, 2024 | prnewswire.comDynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S.May 11, 2024 | finance.yahoo.comAnalysts Are Updating Their Dynavax Technologies Corporation (NASDAQ:DVAX) Estimates After Its First-Quarter ResultsMay 10, 2024 | finance.yahoo.comDynavax Technologies Corp (DVAX) Q1 2024 Earnings: Aligns with EPS Projections, Surpasses ...May 10, 2024 | finance.yahoo.comDynavax Technologies First Quarter 2024 Earnings: Misses ExpectationsMay 10, 2024 | seekingalpha.comDynavax: HEPLISAV-B Growth Up, Pipeline UncertainMay 9, 2024 | insidermonkey.comDynavax Technologies Corporation (NASDAQ:DVAX) Q1 2024 Earnings Call TranscriptMay 9, 2024 | marketbeat.comDynavax Technologies (NASDAQ:DVAX) Reaches New 12-Month Low at $10.48Dynavax Technologies (NASDAQ:DVAX) Reaches New 52-Week Low at $10.48May 9, 2024 | finanznachrichten.deDynavax Technologies: Dynavax Reports First Quarter 2024 Financial Results and Provides Business UpdatesMay 9, 2024 | fool.comDynavax Technologies (DVAX) Q1 2024 Earnings Call TranscriptMay 9, 2024 | finance.yahoo.comDynavax Technologies Corp (DVAX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue ...May 8, 2024 | investorplace.comDVAX Stock Earnings: Dynavax Technologies Misses EPS, Misses Revenue for Q1 2024May 8, 2024 | prnewswire.comDynavax Reports First Quarter 2024 Financial Results and Provides Business UpdatesMay 7, 2024 | markets.businessinsider.comDynavax Technologies earnings preview: what Wall Street is expectingMay 7, 2024 | msn.comDynavax Q1 2024 Earnings PreviewMay 6, 2024 | marketbeat.comDynavax Technologies Co. (NASDAQ:DVAX) Position Decreased by Fisher Asset Management LLCFisher Asset Management LLC cut its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 16.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,389,950 shares of the biopharmaceutiMay 1, 2024 | marketbeat.comDynavax Technologies (DVAX) to Release Earnings on WednesdayDynavax Technologies (NASDAQ:DVAX) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=588979)April 30, 2024 | markets.businessinsider.comBiotech Stocks Facing FDA Decision In May 2024April 24, 2024 | finance.yahoo.comDynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024April 23, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Buys 76,728 Shares of Dynavax Technologies Co. (NASDAQ:DVAX)Allspring Global Investments Holdings LLC increased its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 185.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 118,074 shares of the biopharmaceutical company's stock aApril 18, 2024 | marketbeat.comFederated Hermes Inc. Sells 1,264,059 Shares of Dynavax Technologies Co. (NASDAQ:DVAX)Federated Hermes Inc. lessened its position in Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 10.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,364,666 shares of the biopharmaceuticaApril 17, 2024 | marketbeat.comStockNews.com Lowers Dynavax Technologies (NASDAQ:DVAX) to HoldStockNews.com cut shares of Dynavax Technologies from a "buy" rating to a "hold" rating in a research report on Wednesday.April 11, 2024 | marketbeat.comPeregrine Capital Management LLC Decreases Stock Holdings in Dynavax Technologies Co. (NASDAQ:DVAX)Peregrine Capital Management LLC reduced its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 14.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 527,334 shares of the biopharmaceutical compApril 9, 2024 | stocknews.com3 Biotech Buys Under $15April 3, 2024 | marketbeat.comVanguard Group Inc. Boosts Stake in Dynavax Technologies Co. (NASDAQ:DVAX)Vanguard Group Inc. lifted its position in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 3.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,146,891 shares of the bApril 2, 2024 | marketbeat.comDynavax Technologies Co. (NASDAQ:DVAX) Sees Large Increase in Short InterestDynavax Technologies Co. (NASDAQ:DVAX - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 17,350,000 shares, a growth of 6.0% from the February 29th total of 16,370,000 shares. Based on an average daily volume of 1,960,000 shares, the days-to-cover ratio is presently 8.9 days.April 2, 2024 | marketbeat.comChicago Capital LLC Sells 98,406 Shares of Dynavax Technologies Co. (NASDAQ:DVAX)Chicago Capital LLC cut its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX - Free Report) by 1.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,693,329 shares of the biopharmaceutical company's stock aftMarch 25, 2024 | finance.yahoo.comThose who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68%March 24, 2024 | seekingalpha.comDynavax Technologies: Still A BelieverMarch 24, 2024 | seekingalpha.comDynavax Technologies: Still A BelieverMarch 23, 2024 | seekingalpha.comDynavax: Holding Firm Despite Its Missing Cash CowMarch 23, 2024 | seekingalpha.comDynavax: Holding Firm Despite Its Missing Cash CowMarch 19, 2024 | marketbeat.comDynavax Technologies Co. (NASDAQ:DVAX) Short Interest Up 9.1% in FebruaryDynavax Technologies Co. (NASDAQ:DVAX - Get Free Report) was the target of a significant increase in short interest during the month of February. As of February 29th, there was short interest totalling 16,370,000 shares, an increase of 9.1% from the February 14th total of 15,000,000 shares. Based on an average daily trading volume, of 1,900,000 shares, the short-interest ratio is currently 8.6 days.March 15, 2024 | bizjournals.comHow vaccine maker Dynavax tested itself and found a corporate cure Get Dynavax Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.” Click here to find out who they are. DVAX Media Mentions By Week DVAX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DVAX News Sentiment▼0.260.75▲Average Medical News Sentiment DVAX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DVAX Articles This Week▼73▲DVAX Articles Average Week Get Dynavax Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PRTA News Today URGN News Today GTHX News Today PBYI News Today MRNS News Today HALO News Today IONS News Today MDGL News Today ALKS News Today FOLD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DVAX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynavax Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
